Activity of rat UGT1A1 towards benzo[a]pyrene phenols and dihydrodiols

被引:3
作者
Webb, L [1 ]
Miles, K [1 ]
Kessler, F [1 ]
Ritter, JK [1 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
UDP-glucuronosyltransferase; benzo[a]pyrene; glucuronidation; environmental carcinogenesis;
D O I
10.1016/j.etap.2005.07.018
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Four UDP-glucuronosyltransferases from the rat UGT1A family were tested for activity towards benzo[a]pyrene pyenols and dihydrodiols. UGTIA1 and UGTI1A7 were found to be broadly active towards BaP metabolites. Antisera recognizing rat UGT1A1 and UGT1A7 were used to assess UGT levels in relation to UGT activity towards benzo[a]pyrene-7.8-dihydrodiol (BPD). The rank BPD UGT activities were liver=intestine kidney, whereas UGT1A1 was highest in liver and UGT1A7 was highest in intestine. Phenobarbital, an inducer of hepatic UGT1A1, only slightly increased BPD UGT activity, whereas UGT1A7 inducers more potently increased the activity. Inhibition studies using the differential UGTIAI inhibitor, bilirubin, suggest that UGT1A1 is not a major contributor to the constitutive BPD glucuronidating activity of control rat liver microsomes. These data suggest that multiple UGT1A enzymes contribute to glucuronidation of BPD and other BaP metabolites, and that their relative contributions depend on tissue- and environmental-specific factors. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 50 条
  • [1] Evolution of the activity of UGT1A1 throughout the development and adult life in a rat
    Bustamante, N
    Cantarino, MH
    Arahuetes, RM
    Cubero, FJ
    Ortiz, A
    LIFE SCIENCES, 2006, 78 (15) : 1688 - 1695
  • [2] Estimating the Differences of UGT1A1 Activity in Recombinant UGT1A1 Enzyme, Human Liver Microsomes and Rat Liver Microsome Incubation Systems in Vitro
    Wang, Qi
    Dai, Zhong
    Wen, Binyu
    Ma, Shuangcheng
    Zhang, Yujie
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (12) : 1910 - 1917
  • [3] Polymorphisms of UGT1A1*6, UGT1A1*27 & UGT1A1*28 in three major ethnic groups from Malaysia
    Teh, L. K.
    Hashim, H.
    Zakaria, Z. A.
    Salleh, M. Z.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2012, 136 (02) : 249 - 259
  • [4] Effects of Japanese Herbal Medicine, Kampo, on Human UGT1A1 Activity
    Katoh, Miki
    Yoshioka, Yuko
    Nakagawa, Nao
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2009, 24 (03) : 226 - 234
  • [5] Inhibition of UGT1A1 by natural and synthetic flavonoids
    Liu, Xin-Yu
    Lv, Xia
    Wang, Ping
    Ai, Chun-Zhi
    Zhou, Qi-Hang
    Finel, Moshe
    Fan, Bin
    Cao, Yun-Feng
    Tang, Hui
    Ge, Guang-Bo
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 126 : 653 - 661
  • [6] High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk
    Dura, Polat
    Salomon, Jody
    Morsche, Rene H. M. Te
    Roelofs, Hennie M. J.
    Kristinsson, Jon O.
    Wobbes, Theo
    Witteman, Ben J. M.
    Tan, Adriaan C. I. T. L.
    Drenth, Joost P. H.
    Peters, Wilbert H. M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) : 1789 - 1796
  • [7] Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity
    Mohamed, Mohamed-Eslam F.
    Tseng, Tiffany
    Frye, Reginald E.
    XENOBIOTICA, 2010, 40 (10) : 663 - 669
  • [8] Interethnic Variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population
    Abudahab, Sara
    Hakooz, Nancy
    Jarrar, Yazun
    Al Shhab, Mohammad
    Saleh, Ahmad
    Zihlif, Malek
    Dajani, Rana
    CURRENT DRUG METABOLISM, 2019, 20 (05) : 399 - 410
  • [9] Association of gallstone and polymorphisms of UGT1A1*27 and UGT1A1*28 in patients with hepatitis B virus-related liver failure
    Zhuo, Haiyan
    Fan, Jinhai
    Zhang, Bifeng
    Shi, Yixian
    Zheng, Liqing
    Chai, Yihong
    Yao, Lvfeng
    OPEN MEDICINE, 2022, 17 (01): : 1455 - 1465
  • [10] Mechanism of in-vitro inhibition of UGT1A1 by paritaprevir
    Alam, Novera
    Angeli, Mia G.
    Greenblatt, David J.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2017, 69 (12) : 1794 - 1801